相关实验视频
Updated: Aug 27, 2026

08:50
Depletion and Reconstitution of Macrophages in Mice
Published on: August 1, 2012
通过调节FXR-NLRP3介导的巨细胞亡,缓解大肠炎
Lijiao Yang1, Wanyu Li1, Qianjing Zhao1
1Department of Gastroenterology and Hepatology, General Hospital, Tianjin Medical University, National Key Clinical Specialty, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases, Tianjin, 300052, People's Republic of China.
Journal of inflammation research
|March 11, 2025
概括
萨卡罗米切斯布拉迪超 (SbS) 通过激活FXR和抑制NLRP3炎症酶来缓解性结肠炎 (UC),从而减少巨细胞的烧灭. 这种益生菌干预为炎症性肠病 (IBD) 提供了一种新的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 性结肠炎 (UC) 是一种主要的炎症性肠病 (IBD),其特征是结肠粘膜炎症.
- 糖菌 (Saccharomyces boulardii) (Sb) 是一种用于消化系统疾病的益生菌酵母,但其缓解大肠炎的确切机制尚未完全理解.
- 新出现的证据强调了Farnesoid X受体 (FXR) 在UC中的作用及其与NLRP3炎症酶的调节相互作用.
研究的目的:
- 调查Sb超剂 (SbS) 对大肠炎的治疗作用.
- 阐明FXR-NLRP3信号通路在SbS介导的大肠炎改善中的作用.
主要方法:
- 通过使用硫酸 (DSS) 诱导大肠炎的小鼠模型.
- 小鼠用SbS或对照介质进行治疗.
- 在体内和体外评估了FXR激活,NLRP3炎症酶抑制和巨细胞灭.
主要成果:
- SbS治疗改善了DSS诱导的大肠炎的症状.
- 在结肠组织中,SbS激活了FXR并抑制了NLRP3的表达.
- 在巨细胞中,SbS降低了分裂的caspase-1表达,减轻了热亡.
- 抑制FXR逆转了SbS的治疗效果,增加了热.
结论:
- 通过调节FXR-NLRP3信号通路,SbS可以缓解UC.
- SbS减轻了巨细胞的灭,为UC提供了潜在的治疗方法.
- 这项研究为Sb在UC中发挥有益作用的机制提供了新的见解.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
Dysbiosis of the Gut Microbiota
The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

